Abstract | OBJECTIVE: DESIGN: A prospective randomized study. SETTING: Cardiac center of a tertiary care, referral hospital. PARTICIPANTS: INTERVENTIONS: MAIN RESULT: Control group had the longest sternal closure time, maximum blood loss at 24 hours, and maximum requirements of blood and blood products. Among the 2 groups given antifibrinolytics, there was no significant difference in postoperative blood loss, blood and product requirement, and reexploration rates. CONCLUSION:
|
Authors | Sandeep Chauhan, Sambhu N Das, Akshay Bisoi, Shailaja Kale, Usha Kiran |
Journal | Journal of cardiothoracic and vascular anesthesia
(J Cardiothorac Vasc Anesth)
Vol. 18
Issue 2
Pg. 141-3
(Apr 2004)
ISSN: 1053-0770 [Print] United States |
PMID | 15073700
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Antifibrinolytic Agents
- Heparin Antagonists
- Protamines
- Tranexamic Acid
- Aminocaproic Acid
|
Topics |
- Adolescent
- Aminocaproic Acid
(therapeutic use)
- Antifibrinolytic Agents
(therapeutic use)
- Blood Coagulation Tests
- Blood Transfusion
(methods)
- Cardiac Surgical Procedures
- Cardiopulmonary Bypass
- Child
- Child, Preschool
- Female
- Heart Defects, Congenital
(blood, surgery)
- Heparin Antagonists
(therapeutic use)
- Humans
- Infant
- Male
- Postoperative Hemorrhage
(prevention & control)
- Prospective Studies
- Protamines
(therapeutic use)
- Time Factors
- Tranexamic Acid
(therapeutic use)
- Treatment Outcome
|